The Focal Hepatic Lesion: Radiologic Assessment
|
|
- Lynette Campbell
- 6 years ago
- Views:
Transcription
1 The Focal Hepatic Lesion: Radiologic Assessment Kevin Kuo, Harvard Medical School Year III
2 Our Patient: PS 67 y/o female w/ long history of alcohol use Drinking since age 18, up to one bottle of wine/day Asymptomatic, denies abdominal distension, hematemesis, ascites, encephalopathy 2
3 What Net? Given PS s etensive history of alcohol use, we are clearly concerned about potential cirrhosis and even hepatocellular carcinoma (HCC). However, we need to understand basic liver anatomy to appreciate liver imaging 3
4 Liver Anatomy Couinaud Segments Based on vascular anatomy Important for surgical planning Portal Triad and Hepatic Veins Hepatic veins delineate lobes of the liver: Left (lateral and medial) and Right (anterior and posterior) 4
5 Screening for HCC: The Menu of Tests Imaging Modality Accuracy* Advantages Disadvantages US Sens:60% Spec:97% Wide availability, noninvasive, no radiation. Assess vascular invasion. Good for screening. Real time images Operator dependent, low sensitivity, may not always distinguish between tumors CT Sens:68% Spec: 93% Improved sensitivity with triple phase helical CT, relatively fast Increased radiation, more costly MRI Sens: 81% Spec: 85% Most sensitive, especially for smaller lesions. High resolution, no radiation Most epensive, takes more time, patient tolerance *For HCC In patients with chronic liver disease 5
6 Triple Phase Helical CT Aial C+ CT Arterial Phase Aial C+ CT Portal Venous Phase Aial C+ CT Hepatic Venous Phase Contrast Injection Arterial Portal Venous Hepatic Venous Time (sec) Foley, WD. Multiphase Hepatic CT with a Multirow Detector CT Scanner (175):
7 PS: Cirrhosis and Portal Hypertension Film Findings: Nodular, shrunken liver Caudate and left lateral lobe enlargement Esophageal Varices Umbilical Recanalization Enlarged Portal Vein Splenomegaly, Ascites (neither present in our patient) PACS, BIDMC Aial C+ CT Venous Maimum Intensity Phase Reconstruction Aial C+ CT 7
8 PS: Triple Phase CT Aial C- CT Aial C+ CT: Arterial Phase Film Findings: Nodular liver No discrete lesions Early hyperenhancing lesion PACS, BIDMC 8
9 PS: Triple Phase CT Aial C+ CT: Portal Venous Phase Aial C+ CT: Delayed Phase Film Findings: Quick washout of enhancing lesion Hypoenhancing lesion with peripheral rim of enhancement PACS, BIDMC 9
10 PS: Preliminary Diagnosis Triple Phase CT Findings: Early arterial phase enhancement quick washout peripheral rim of enhancement in the delayed phase Highly suspicious for HCC HCC is hypervascular receives ~80% of its blood flow from hepatic arteries and only ~20% from the portal vein (eact opposite of normal liver parenchyma) Nonetheless, we need to consider the full differential diagnosis 10
11 A Walk Through The Differential Diagnoses: Lesions Classical CT Findings PS Hepatic Cyst Hemangioma Focal Nodular Hyperplasia (FNH) Hepatocellular Adenoma Metastasis Abscess Hepatocellular Carcinoma (HCC) Sharply demarcated wall, water density, nonenhancing Peripheral filling in of contrast over time Light Bulb Sign on T2 MRI Early filling in arterial phase with central filling defect (scar) Variable, central changes due to hemorrhage often seen Mostly multiple low attenuation lesions, rim enhancement without filling in Well demarcated hypodense areas with peripheral enhancement, may see gas Early arterial enhancement, fast washout, delayed fibrous capsule enhancement 11
12 Hepatic Cyst Aial C+ CT Film Findings: Sharply demarcated, non enhancing, water-dense cyst. ol/heparad/ 12
13 A Walk Through The Differential Diagnoses: Lesions Hepatic Cyst Hemangioma Focal Nodular Hyperplasia (FNH) Hepatocellular Adenoma Metastasis Abscess Hepatocellular Carcinoma (HCC) Classical CT Findings Sharply demarcated wall, water density, nonenhancing Peripheral filling in of contrast over time Light Bulb Sign on T2 MRI Early filling in arterial phase with central filling defect (scar) Variable, central changes due to hemorrhage often seen Mostly multiple low attenuation lesions, rim enhancement without filling in Well demarcated hypodense areas with peripheral enhancement, may see gas Early arterial enhancement, fast washout, delayed fibrous capsule enhancement PS 13
14 Hemangioma Aial C+ CT (Various phases) Film Findings: Hypodense lesion with peripheral filling in of contrast over time 14
15 A Walk Through The Differential Diagnoses: Lesions Hepatic Cyst Hemangioma Focal Nodular Hyperplasia (FNH) Hepatocellular Adenoma Metastasis Abscess Hepatocellular Carcinoma (HCC) Classical CT Findings Sharply demarcated wall, water density, nonenhancing Peripheral filling in of contrast over time Light Bulb Sign on T2 MRI Early filling in arterial phase with central filling defect (scar) Variable, central changes due to hemorrhage often seen Mostly multiple low attenuation lesions, rim enhancement without filling in Well demarcated hypodense areas with peripheral enhancement, may see gas Early arterial enhancement, fast washout, delayed fibrous capsule enhancement PS 15
16 Focal Nodular Hyperplasia Aial C+ CT Film Findings: Enhancing lesion with central filling defect (central scar) se6a.htm 16
17 A Walk Through The Differential Diagnoses: Lesions Hepatic Cyst Hemangioma Focal Nodular Hyperplasia (FNH) Hepatocellular Adenoma Metastasis Abscess Hepatocellular Carcinoma (HCC) Classical CT Findings Sharply demarcated wall, water density, nonenhancing Peripheral filling in of contrast over time Light Bulb Sign on T2 MRI Early filling in arterial phase with central filling defect (scar) Variable, central changes due to hemorrhage often seen Mostly multiple low attenuation lesions, rim enhancement without filling in Well demarcated hypodense areas with peripheral enhancement, may see gas Early arterial enhancement, fast washout, delayed fibrous capsule enhancement PS 17
18 Hepatocellular Adenoma Aial C+ CT Film Findings: Multiple hypoenhancing heterogenous lesions Enhancing hepatic veins UpToDate: Hepatic Adenoma 18
19 A Walk Through The Differential Diagnoses: Lesions Hepatic Cyst Hemangioma Focal Nodular Hyperplasia (FNH) Hepatocellular Adenoma Metastasis Abscess Hepatocellular Carcinoma (HCC) Classical CT Findings Sharply demarcated wall, water density, nonenhancing Peripheral filling in of contrast over time Light Bulb Sign on T2 MRI Early filling in arterial phase with central filling defect (scar) Variable, central changes due to hemorrhage often seen Mostly multiple low attenuation lesions, rim enhancement without filling in Well demarcated hypodense areas with peripheral enhancement, may see gas Early arterial enhancement, fast washout, delayed fibrous capsule enhancement PS 19
20 Liver Metastasis (Colonic Adenocarcinoma) Aial C+ CT Film Findings: Multiple hypoenhancing heterogenous lesions jpg 20
21 A Walk Through The Differential Diagnoses: Lesions Hepatic Cyst Hemangioma Focal Nodular Hyperplasia (FNH) Hepatocellular Adenoma Metastasis Abscess Hepatocellular Carcinoma (HCC) Classical CT Findings Sharply demarcated wall, water density, nonenhancing Peripheral filling in of contrast over time Light Bulb Sign on T2 MRI Early filling in arterial phase with central filling defect (scar) Variable, central changes due to hemorrhage often seen Mostly multiple low attenuation lesions, rim enhancement without filling in Well demarcated hypodense areas with peripheral enhancement, may see gas Early arterial enhancement, fast washout, delayed fibrous capsule enhancement PS 21
22 Liver Abscess Aial C+ CT Film Findings: Well demaracated hypoenhancing lesion Rim of increased enhancement relative to central region 22
23 A Walk Through The Differential Diagnoses: Lesions Hepatic Cyst Hemangioma Focal Nodular Hyperplasia (FNH) Hepatocellular Adenoma Metastasis Abscess Hepatocellular Carcinoma (HCC) Classical CT Findings Sharply demarcated wall, water density, nonenhancing Peripheral filling in of contrast over time Light Bulb Sign on T2 MRI Early filling in arterial phase with central filling defect (scar) Variable, central changes due to hemorrhage often seen Mostly multiple low attenuation lesions, rim enhancement without filling in Well demarcated hypodense areas with peripheral enhancement, may see gas Early arterial enhancement, fast washout, delayed fibrous capsule enhancement PS 23
24 PS: Hepatocellular Carcinoma Aial CT (various phases) Film Findings: Early arterial enhancement Quick washout Peripheral rim of enhacement PACS, BIDMC 24
25 A Walk Through The Differential Diagnoses: Lesions Hepatic Cyst Hemangioma Focal Nodular Hyperplasia (FNH) Hepatocellular Adenoma Metastasis Abscess Hepatocellular Carcinoma (HCC) Classical CT Findings Sharply demarcated wall, water density, nonenhancing Peripheral filling in of contrast over time Light Bulb Sign on T2 MRI Early filling in arterial phase with central filling defect (scar) Variable, central changes due to hemorrhage often seen Mostly multiple low attenuation lesions, rim enhancement without filling in Well demarcated hypodense areas with peripheral enhancement, may see gas Early arterial enhancement, fast washout, delayed fibrous capsule enhancement PS 25
26 PS: The Final Diagnosis Ultrasound guided biopsy confirmed the diagnosis Hepatocellular Carcinoma 26
27 HCC: MR Imaging Aial T1 Weighted MR Precontrast Aial T1 Weighted MR Arterial Phase Aial T1 Weighted MR Portal-phase Variable intensity on T1 and T2 weighted imaging Early arterial phase enhancement Quick washout Rim enhancement of fibrous capsule in portal/delayed phases Ito, K. Hepatocellular carcinoma: Conventional MRI findings including gadolinium-enhanced dynamic imaging (58):
28 Hepatocellular Carcinoma: Background Incidence: 2.5/100,000 in US vs. 50/100,000 in East Asia, Median survival after diagnosis: ~ 12 months Projected to be the worldwide leading cause of cancer mortality by 2010 (WHO) Causes: Hepatitis B and/or C, Cirrhosis, Aflatoins, Hemochromatosis Diagnosis of HCC gives bonus points for transplantation evaluation based on the Model for End Stage Liver Disease (MELD) May be a focal lesion, dominant lesion with satellites, or diffusely infiltrating 28
29 HCC: Treatment Options Treatment: Resection Optimal Candidate: Solitary lesion, no vascular invasion, preserved hepatic function Patient PS X Cirrhotic, poor hepatic reserve Transplant Radiofrequency Ablation Chemoembolization Unresectable patients w/ solitary lesion < 5cm or <3 lesions of <3 cm. No vascular invasion or metastases Do not meet resectability/transplant criteria but disease confined to liver Large unresectable tumors not amenable to RFA. Absence of portal vein thrombosis or encephalopathy X EtOH found at transplant eval. X RFA more appropriate 29
30 Radiofrequency Ablation: Guidance US Guidance CT Guidance Aial C- CT Film Findings: RFA needle in tumor
31 PS: RFA Ultrasound Aial US: Lesion Pre-RFA Aial US: Lesion Post-RFA Film Findings: Hypoechoic lesion with poorly defined borders. Hyperechoic region with dirty shadowing (air bubbles from RF procedure) PACS, BIDMC 31
32 PS: Post-RFA Images Aial CT C+ Immediately after RFA Procedure Aial CT C+ 5 months after RFA Procedure Film Findings: Post-Ablational Hyperemia Lesion no longer enhances No new enhancing lesions PACS, BIDMC 32
33 PS: The Outcome While not definitively cured, RF ablation was considered to be successful and our patient is doing relatively well. 33
34 Summary Several modalities available for hepatic imaging (US, CT, MRI) Differential D for focal hepatic lesion Use of different enhancement patterns to distinguish between lesions Treatment options available for HCC Radiofrequency Ablation 34
35 Acknowledgements: Fabio Komlos, MD Andrew Bennett, MD Andrew Hines-Peralta, MD Pamela Lepkowski Larry Barbaras 35
36 References: Fernandez MP, Redvanly RD. Primary Hepatic Malignant Neoplasms. Radiologic Clinics of North America. (1998) 36: Ferrucci JT. Liver Tumor Imaging. Radiologic Clinics of North America. (1994) 32: Foley DW, Mallisee TA, Taylor AJ. Multiphase Hepatic CT with a Multirow Detector CT Scanner. American Journal of Radiology. (2000) 175: Hoon J, McTavish J, Mortele JK, Wiesner W, Ros PR. Hepatic Imaging with Multidetector CT. Radiographics. (2001) 21: Ito K. Hepatocellular Carcionma: Conventional MRI findings including gadoliniumenhanced dynamic imaging. European Journal of Radiology (2006) 58: Kamel IR, Bluemke DA. Imaging Evaluation of Hepatocellular carcinoma. Journal of Vascular Interventional Radiology. (2002) 13: Kamel IR, Bluemke DA. MR Imaging of liver tumors. Radiologic Clinics of North America. (2003) 41: Kamel IR, Liapi E, Fishman EK. Multidetector CT of hepatocellular carcinoma. Best Practice and Research Clinical Gastroenterology. (2005) 19: Patel N. Portal Hypertension. Seminars in Roentgenology. (2002) 37: Taylor HM, Ros PR. Hepatic Imaging: An Overview. Radiologic Clinics of North America. (1998) 36:
HEPATO-BILIARY IMAGING
HEPATO-BILIARY IMAGING BY MAMDOUH MAHFOUZ MD PROF.OF RADIOLOGY CAIRO UNIVERSITY mamdouh.m5@gmail.com www.ssregypt.com CT ABDOMEN Indications Patient preparation Patient position Scanogram Fasting 4-6 hours
More informationImaging of liver and pancreas
Imaging of liver and pancreas.. Disease of the liver Focal liver disease Diffusion liver disease Focal liver disease Benign Cyst Abscess Hemangioma FNH Hepatic adenoma HCC Malignant Fibrolamellar carcinoma
More informationLiver Tumors. Prof. Dr. Ahmed El - Samongy
Liver Tumors Prof. Dr. Ahmed El - Samongy Objective 1. Identify the most important features of common benign liver tumors 2. Know the risk factors, diagnosis, and management of hepatocellular carcinoma
More informationEvaluation of Liver Mass Lesions. American College of Gastroenterology 2013 Regional Postgraduate Course
Evaluation of Liver Mass Lesions American College of Gastroenterology 2013 Regional Postgraduate Course Lewis R. Roberts, MB ChB, PhD Division of Gastroenterology and Hepatology Mayo Clinic College of
More informationLiver Cancer And Tumours
Liver Cancer And Tumours What causes liver cancer? Many factors may play a role in the development of cancer. Because the liver filters blood from all parts of the body, cancer cells from elsewhere can
More informationWenxin Xu, Harvard Medical School Year III. Gillian Lieberman, MD
August 2011 Wenxin Xu, Harvard Medical School Year III Primary liver tumor, typically in setting of chronic liver disease Viral hepatitis (HBV, HCV) in 80% of cases 2nd leading cause of cancer death worldwide
More informationAlice Fung, MD Oregon Health and Science University
Alice Fung, MD Oregon Health and Science University Disclosure Comments The speaker Alice Fung, MD Has relevant financial relationships to disclose. Received honorarium from (Guerbet). This individual
More informationMalignant Focal Liver Lesions
Malignant Focal Liver Lesions Other Than HCC Pablo R. Ros, MD, MPH, PhD Departments of Radiology and Pathology University Hospitals Cleveland Medical Center Case Western Reserve University Pablo.Ros@UHhospitals.org
More informationRadiology of hepatobiliary diseases
GI cycle - Lecture 14 436 Teams Radiology of hepatobiliary diseases Objectives 1. To Interpret plan x-ray radiograph of abdomen with common pathologies. 2. To know the common pathologies presentation.
More informationHepatocellular Carcinoma: Diagnosis and Management
Hepatocellular Carcinoma: Diagnosis and Management Nizar A. Mukhtar, MD Co-director, SMC Liver Tumor Board April 30, 2016 1 Objectives Review screening/surveillance guidelines Discuss diagnostic algorithm
More informationLIVER IMAGING TIPS IN VARIOUS MODALITIES. M.Vlychou, MD, PhD Assoc. Professor of Radiology University of Thessaly
LIVER IMAGING TIPS IN VARIOUS MODALITIES M.Vlychou, MD, PhD Assoc. Professor of Radiology University of Thessaly Hepatocellular carcinoma is a common malignancy for which prevention, screening, diagnosis,
More informationFinancial Disclosure
Benign Liver Masses Adil Abdalla, MBBS Creighton University-CHI Health August 25, 2018 Financial Disclosure Nothing to disclose Financial Disclosure 1 Objectives To assess patients with benign liver tumors
More informationCTA/MRA of Pediatric Hepatic Masses Radiology-Pathology Correlation
Acta Radiológica Portuguesa, Vol.XVIII, nº70, pág. 41-50, Abr.-Jun., 2006 CTA/MRA of Pediatric Hepatic Masses Radiology-Pathology Correlation Marilyn J. Siegel Mallinckrodt Institute of Radiology, Washington
More informationWorkup of a Solid Liver Lesion
Workup of a Solid Liver Lesion Joseph B. Cofer MD FACS Chief Quality Officer Erlanger Health System Affiliate Professor of Surgery UTHSC-Chattanooga I have no financial or other relationships with any
More informationInternational Journal of Current Medical Sciences- Vol. 6, Issue,, pp , June, 2016 A B S T R A C T
ISSN: 2320-8147 International Journal of Current Medical Sciences- Vol. 6, Issue,, pp. 122-126, June, 2016 COMPUTED TOMOGRAPHY IN HEPATIC METASTASES Ananthakumar P and Adaikkappan M., Available online
More informationRadiological Reasoning: Incidentally Discovered Liver Mass
AJR Integrative Imaging LIFELONG LEARNING FOR RADIOLOGY This Radiological Reasoning article is available for SAM credit and CME credits when completed with the additional educational material provided
More informationLiver Cancer (Hepatocellular Carcinoma or HCC) Overview
Liver Cancer (Hepatocellular Carcinoma or HCC) Overview Recent advances in liver cancer care seek to address the rising incidence of liver cancer, which has steadily increased over the past three decades.
More informationLiver Ultrasound - Beyond the Basics. Pamela Parker Lead Sonographer
Liver Ultrasound - Beyond the Basics Pamela Parker Lead Sonographer Aims Review what we know about the liver Reasons for imaging Focal lesions Diffuse disease Can we do more? The Liver The Liver The Liver
More informationNormal Sonographic Anatomy
hapter 2:The Liver DUNSTAN ABRAHAM Normal Sonographic Anatomy Homogeneous, echogenic texture (Figure 2-1) Measures approximately 15 cm in length and 10 12.5 cm anterior to posterior; measurement taken
More informationImaging of common diseases of hepatobiliary and GI system
Imaging of common diseases of hepatobiliary and GI system Natthaporn Tanpowpong, M.D. Diagnostic radiology Faculty of Medicine, Chulalongkorn University Normal plain radiograph A = Common bile duct
More informationInteresting Cases from Liver Tumor Board. Jeffrey C. Weinreb, M.D.,FACR Yale University School of Medicine
Interesting Cases from Liver Tumor Board Jeffrey C. Weinreb, M.D.,FACR Yale University School of Medicine jeffrey.weinreb@yale.edu Common Liver Diseases Hemangioma Cyst FNH Focal Fat/Sparing THID Non-Cirrhotic
More informationSurveillance for Hepatocellular Carcinoma
Surveillance for Hepatocellular Carcinoma Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded on April
More informationACG Clinical Guideline: Diagnosis and Management of Focal Liver Lesions
ACG Clinical Guideline: Diagnosis and Management of Focal Liver Lesions Jorge A. Marrero, MD, 1 Joseph Ahn, MD, FACG, 2 K. Rajender Reddy, MD, FACG 3 1 University of Texas at Southwestern, Dallas, Texas,
More informationHCC Imaging and Advances in Locoregional Therapy. David S. Kirsch MD Ochsner Clinic Foundation
HCC Imaging and Advances in Locoregional Therapy David S. Kirsch MD Ochsner Clinic Foundation -Nothing to disclose Hepatic Imaging Primary imaging modalities include: US CT MR Angiography Nuclear medicine
More informationNewcastle HPB MDM updated radiology imaging protocol recommendations. Author Dr John Scott. Consultant Radiologist Freeman Hospital
Newcastle HPB MDM updated radiology imaging protocol recommendations Author Dr John Scott. Consultant Radiologist Freeman Hospital This document is intended as a guide to aid radiologists and clinicians
More informationHepatocellular Carcinoma HCC Updated November 2015 by: Dr. Mohammed Alghamdi (Medical Oncology Fellow, University of Calgary)
Hepatocellular Carcinoma HCC Updated November 2015 by: Dr. Mohammed Alghamdi (Medical Oncology Fellow, University of Calgary) Staff Reviewers: Dr. Yoo Joung Ko (Medical Oncologist, Sunnybrook Odette Cancer
More informationHEPATOCYTE SPECIFIC CONTRAST MEDIA: WHERE DO WE STAND?
HEPATOCYTE SPECIFIC CONTRAST MEDIA: WHERE DO WE STAND? Andrew T. Trout, MD @AndrewTroutMD Disclosures No relevant disclosures Outline Review of hepatocyte specific contrast media Review of hepatocellular
More informationEssentials of Clinical MR, 2 nd edition. 65. Benign Hepatic Masses
65. Benign Hepatic Masses Pulse sequences acquired for abdominal MRI typically consist of fast acquisition schemes such as single-shot turbo spin echo (i.e. HASTE) and gradient echo schemes such as FLASH
More informationLearning Objectives. After attending this presentation, participants will be able to:
Learning Objectives After attending this presentation, participants will be able to: Describe HCV in 2015 Describe how to diagnose advanced liver disease and cirrhosis Identify the clinical presentation
More informationInnovations in HCC Imaging: MDCT/MRI
Innovations in HCC Imaging: MDCT/MRI Anthony E. Cheng, M.D. Cardinal MRI Center Cardinal Santos Medical Center, Wilson Street, San Juan Innovations in HCC Imaging: Goals/Objectives MDCT/MRI Learn the diagnostic
More informationAcknowledgements. Update of Focal Liver Lesions Goals. Focal Liver Lesions. Imaging Choices For Liver Lesions. Focal Liver Lesions
Acknowledgements Update of Focal Liver Lesions 2012 Giles Boland Massachusetts General Hospital Harvard Medical School No disclosures Dushyant Sahani Mukesh Harisinghani Goals Focal liver lesions Imaging
More informationFive Views of Transitional Cell Carcinoma: One Man s Journey
September 2006 Five Views of Transitional Cell Carcinoma: One Man s Journey Amsalu Dabela, Harvard Medical School III Outline Overview: Renal Anatomy Our Patient s Story Diagnostic Imaging Studies Appearance
More informationUPDATE TO THE MANAGEMENT OF PATIENTS WITH HCC HCA
UPDATE TO THE MANAGEMENT OF PATIENTS WITH HCC HUSSEIN K. MOHAMED MD, FACS. Transplant and Hepato-biliary Surgery Largo Medical Center HCA DISCLOSURE I have no financial relationship(s) relevant to the
More informationRICCARDO LENCIONI,CLOTILDE DELLA PINA, LAURA CROCETTI,DANIA CIONI. Chapter 1
RICCARDO LENCIONI,CLOTILDE DELLA PINA, LAURA CROCETTI,DANIA CIONI Chapter 1 Impact of European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) Guidelines on the Use of Contrast
More informationModern liver imaging techniques - A new era in liver ultrasound
Modern liver imaging techniques - A new era in liver ultrasound Yuko Kono, M.D., Ph.D. Clinical Professor Departments of Medicine and Radiology University of California, San Diego San Diego, USA How to
More informationAlison Douglass Gillian Lieberman, MD. November. Colon Cancer. Alison Douglass, Harvard Medical School Year III Gillian Lieberman, MD
November Colon Cancer Alison Douglass, Harvard Medical School Year III Our Patient Mr. K. is a 67 year old man with no prior medical problems other than hemorrhoids which have caused occasional rectal
More informationComplete Summary GUIDELINE TITLE. Liver lesion characterization. BIBLIOGRAPHIC SOURCE(S)
Complete Summary GUIDELINE TITLE Liver lesion characterization. BIBLIOGRAPHIC SOURCE(S) Foley WD, Bree RL, Gay SB, Glick SN, Heiken JP, Huprich JE, Levine MS, Ros PR, Rosen MP, Shuman WP, Greene FL, Rockey
More informationUS-Guided Radiofrequency Ablation of Hepatic Focal Lesions
US-Guided Radiofrequency Ablation of Hepatic Focal Lesions Poster No.: C-2219 Congress: ECR 2011 Type: Scientific Exhibit Authors: D. Armario Bel, A. PLA, F. TERREL, X. Serres; BARCELONA/ES Keywords: Neoplasia,
More informationHepatic Imaging: What Every Practitioner Should Know
Hepatic Imaging: What Every Practitioner Should Know Shuchi K. Rodgers, MD Section Chief, Abdominal Imaging Director of Ultrasound Department of Radiology Einstein Medical Center rodgerss@einstein.edu
More informationAbstract. Introduction. Patients and Methods
The Evaluation of Hepatocellular Carcinoma with Biphasic Contrast enhanced Helical CT Scan J. Yaqoob, V. Bari, M. U. Usman, K. Munir, F. Mosharaf, W. Akhtar Department of Radiology, Aga Khan University
More informationContrast Enhanced Ultrasound of Parenchymal Masses in Children
Contrast Enhanced Ultrasound of Parenchymal Masses in Children Sue C Kaste, DO On behalf of Beth McCarville, MD St. Jude Children s Research Hospital Memphis, TN Overview Share St. Jude experience with
More informationPulmonary Sequestration
July 26, 2004 Pulmonary Sequestration Jonathan Shaw, Harvard Medical School Year IV What do these two patients have in common? Patient 1: 50 y.o. non-smoking female with several months cough and hemoptysis;
More informationHCC and mass effect. Hepatocellular cancer: what if the AFP is rising but no lesion seen on imaging? What you need to know about AFP.
Hepatocellular cancer: what if the AFP is rising but no lesion seen on imaging? Arun J Sanyal M.B.B.S., M.D. Charles Caravati Professor of Medicine Virginia Commonwealth University Imaging features used
More informationTranjugular Intrahepatic Portosystemic Shunt
Tranjugular Intrahepatic Portosystemic Shunt Christopher Selhorst July 25, 2005 BIDMC Radiology Overview Portal Hypertension Indications, Contraindications The Procedure Case Review Complications Outcomes
More informationMALIGNANT HEPATIC NEOPLASMS: USING ULTRASONOGRAPHY AS A MEANS OF DEFINING HEPATIC LESIONS. 1.5 Contact Hours. Presented by: CEU Professor 7
MALIGNANT HEPATIC NEOPLASMS: USING ULTRASONOGRAPHY AS A MEANS OF DEFINING HEPATIC LESIONS 1.5 Contact Hours Presented by: CEU Professor 7 www.ceuprofessoronline.com Copyright 8 2007 The Magellan Group,
More informationHCC e CEUS. Prof. A. Giorgio. Direttore IX UOC di Malattie Infettive ad Indirizzo Ecointerventistico
HCC e CEUS Prof. A. Giorgio Direttore IX UOC di Malattie Infettive ad Indirizzo Ecointerventistico The natural history of compensated cirrhosis due to hepatitis C virus: a 17 year cohort study of 214 patients
More informationHepatocellular Carcinoma: A major global health problem. David L. Wood, MD Interventional Radiology Banner Good Samaritan Medical Center
Hepatocellular Carcinoma: A major global health problem David L. Wood, MD Interventional Radiology Banner Good Samaritan Medical Center Hepatocellular Carcinoma WORLDWIDE The #2 Cancer Killer Overall cancer
More informationHematologic Malignancies of the Liver : Spectrum of Disease. Zhou Jian
Hematologic Malignancies of the Liver : Spectrum of Disease Zhou Jian 2015-7-8 Hematologic malignancies include a wide spectrum of lymphoproliferative and myeloproliferative disorders with nodal and extranodal
More informationObjectives. HCC Incidence and Mortality. Disclosure Statement HCC. Imaging of Hepatocellular Carcinoma. Treatment of Hepatocellular Carcinoma
Imaging of Hepatocellular Carcinoma and the use of LI RADS Treatment of Hepatocellular Carcinoma Aaron D. Anderson, D.O. AOCR April 2015 Objectives Show how the use of LI RADS can simplify the diagnosis
More informationRecently role of non-invasive diagnostics methods
CERTAIN ASPECTS OF NLS-DIAGNOSTICS OF LIVER FOCAL PATHOLOGY A.Y. Shvack, V.I. Nesterov, N.L. Ogluzdina This article contains information about NLS-graphy application in diagnostics of liver focal affections:
More informationImaging techniques to characterize spleen involvement in patients with Hodgkin lymphoma
Imaging techniques to characterize spleen involvement in patients with Hodgkin lymphoma Marco Picardi, MD Ematologia, Azienda Ospedaliera Universitaria Federico II, Naples, Italy 5th International Workshop
More informationSolitary Skull Metastasis as Initial Manifestation of Hepatocellular Carcinoma A Case Report
Solitary Skull Metastasis as Initial Manifestation of Hepatocellular Carcinoma A Case Report Ellyda MN a and Mohd Shafie A b a Department of Radiology, International Islamic University Malaysia, Kuantan,
More informationUse of Ultrasound in NAFLD
Institute for Liver and Digestive Health Use of Ultrasound in NAFLD Dr. Davide Roccarina Specialist in General Medicine Specialist Doctor in Clinical Ultrasound and non-invasive liver assessment Hepatology
More informationJesse Civan, M.D. Medical Director, Jefferson Liver Tumor Center
Liver Tumors Jesse Civan, M.D. Medical Director, Jefferson Liver Tumor Center Differential Diagnosis Malignant Metastatic from non-hepatic primary Hepatocellular carcinoma Cholangiocarcinoma Biliary cystcarcinoma
More informationPrimary Hepatic Neoplasms. estimated 560,000 new cases per year. There is tremendous regional variation in incidence of
Primary Hepatic Neoplasms Hepatocellular Carcinoma Incidence and Epidemiology Worldwide, hepatocellular carcinoma is the 3 rd most common causes of cancer death with an estimated 560,000 new cases per
More informationEnhancements in Hepatobiliary Imaging:
Enhancements in Hepatobiliary Imaging: S. Channual 1, MD; A. Pahwa 2, MD; S. Raman 1, MD. 1 UCLA Medical Center, Department of Radiologic Sciences 2 Olive-View UCLA Medical Center, Department of Radiology
More informationApproach to Liver Lesions. Anjana A. Pillai, MD Associate Professor of Medicine Director, Liver Tumor Clinic The University of Chicago Medical Center
Approach to Liver Lesions Anjana A. Pillai, MD Associate Professor of Medicine Director, Liver Tumor Clinic The University of Chicago Medical Center Objectives Identify common clinical features and imaging
More informationStaging & Current treatment of HCC
Staging & Current treatment of HCC Dr.: Adel El Badrawy Badrawy; ; M.D. Staging & Current ttt of HCC Early stage HCC is typically silent. HCC is often advanced at first manifestation. The selective ttt
More informationLiver imaging takes a step forward with Ingenia
Publication for the Philips MRI Community ISSUE 49 2013 / 2 Liver imaging takes a step forward with Ingenia Lyon South Hospital strives to move from several studies first CT, then MR or PET to using just
More informationImaging in gastric cancer
Imaging in gastric cancer Gastric cancer remains a deadly disease because of late diagnosis. Adenocarcinoma represents 90% of malignant tumors. Diagnosis is based on endoscopic examination with biopsies.
More informationSurveillance for HCC Who, how Diagnosis of HCC Surveillance for HCC in Practice
Surveillance for Hepatocellular Carcinoma Hashem B. El-Serag, MD, MPH Dan L. Duncan Professor of Medicine Chief, Gastroenterology and Hepatology Houston VA & Baylor College of Medicine Houston, TX Outline
More informationRenal masses - the role of diagnostic imaging
Renal masses - the role of diagnostic imaging Poster No.: C-2471 Congress: ECR 2015 Type: Educational Exhibit Authors: V. Rai#; Bjelovar/HR Keywords: Cysts, Cancer, Structured reporting, Ultrasound, MR,
More informationA) PUBLIC HEALTH B) PRESENTATION & DIAGNOSIS
Hepatocellular Carcinoma HCC Updated November 2015 by: Dr. Mohammed Alghamdi (Medical Oncology Fellow, University of Calgary), April 2017 by Dr. Jenny Ko (Medical Oncologist, Abbotsford Centre, BC Cancer
More informationHepatobiliary Malignancies Retrospective Study at Truman Medical Center
Hepatobiliary Malignancies 206-207 Retrospective Study at Truman Medical Center Brandon Weckbaugh MD, Prarthana Patel & Sheshadri Madhusudhana MD Introduction: Hepatobiliary malignancies are cancers which
More informationIT 의료융합 1 차임상세미나 복부질환초음파 이재영
IT 의료융합 1 차임상세미나 2013-4-3 복부질환초음파 이재영 나는오늘누구를위하여 종을울리나? 전통적의료 의사 공학설계자 의사 최첨단진단장비들 USG, CT, MRI 환자 환자 현대의료 사용자중심의사고 US in the Abdomen Detection DDx Look Behavior Response by external stimuli Guiding Tool
More informationHepatocellular Carcinoma (HCC)
Title Slide Hepatocellular Carcinoma (HCC) Professor Muhammad Umar MBBS, MCPS, FCPS (PAK), FACG (USA), FRCP (L), FRCP (G), ASGE-M(USA), AGAF (USA) Chair & Professor of Medicine Rawalpindi Medical College
More informationHepatocellular Carcinoma (HCC): Who Should be Screened and How Do We Treat? Tom Vorpahl MSN, RN, ACNP-BC
Hepatocellular Carcinoma (HCC): Who Should be Screened and How Do We Treat? Tom Vorpahl MSN, RN, ACNP-BC Objectives Identify patient risk factors for hepatocellular carcinoma (HCC) Describe strategies
More informationState-of-the-art minimally invasive interventions for liver tumors
William Lo, HMS MD/PhD candidate, MS III Gillian Lieberman, MD State-of-the-art minimally invasive interventions for liver tumors William Lo, HMS MD/PhD candidate, MS III Gillian Lieberman, MD
More informationImaging of Neuroendocrine Metastases
Imaging of Neuroendocrine Metastases Aoife Kilcoyne, Shaunagh McDermott, Colin McCarthy,Manuel Patino, Dushyant Sahani, Michael Blake Abdominal Imaging Division Massachusetts General Hospital Disclosure
More informationGemstone Spectral Imaging quantifies lesion characteristics for a confident diagnosis
GE Healthcare Gemstone Spectral Imaging quantifies lesion characteristics for a confident diagnosis CT clinical case study lesion characterization Desiree Morgan, MD Vice Chair of Clinical Research Professor
More informationMultiple Primary Quiz
Multiple Primary Quiz Case 1 A 72 year old man was found to have a 12 mm solid lesion in the pancreatic tail by computed tomography carried out during a routine follow up study of this patient with adult
More informationRF Ablation: indication, technique and imaging follow-up
RF Ablation: indication, technique and imaging follow-up Trongtum Tongdee, M.D. Radiology Department, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand Objective Basic knowledge
More informationCT & MRI of Benign Liver Neoplasms Srinivasa R Prasad
CT & MRI of Benign Liver Neoplasms Srinivasa R Prasad No financial disclosures Acknowledgements Many thanks to Drs. Heiken, Narra & Menias (MIR) Dr. Sahani (MGH) for sharing images Benign Liver Tumors:
More informationLiver Tumors. Patient Education. Treatment options 8 4A. About the Liver. Surgical Specialties
Patient Education Treatment options This handout describes different kinds of tumors that form in the liver and how they are treated. About the Liver Your liver is the largest organ in your abdomen. It
More informationLewis R. Roberts, MB, ChB, PhD, FACG
2B: Hot Topics in Liver Disease Evaluation of Liver Mass Lesions Lewis R. Roberts, MB, ChB, PhD, FACG Clinical Classification of Liver Mass Lesions It is helpful to subclassify lesions into three clinical
More informationResident Teaching Conference:
Resident Teaching Conference: Evaluation of the Dreaded Liver Mass May 6, 2011 Sunil Geevarghese, MD, HS 00 Matt Landman, MD Anatomy Overview Couinaud anatomy Resection nomenclature Functional Assessment
More informationPediatric Hepatobiliary, Pancreatic & Splenic US
Pediatric Hepatobiliary, Pancreatic & Splenic US Susan J. Back, MD Department of Radiology, The Children s Hospital of Philadelphia No Disclosures Objectives Normal Abnormal: cases and US advances Objectives
More informationChief Complain. Liver lesion found in routine health check 41 days ago
Chief Complain Liver lesion found in routine health check 41 days ago Present Illness On 2005-7-26 at 台北署立醫院 he underwent a health check for the first time. Abdominal US showed suspicious of a 6*5 cm hepatoma,
More informationHepatobiliary and Pancreatic Malignancies
Hepatobiliary and Pancreatic Malignancies Gareth Eeson MD MSc FRCSC Surgical Oncologist and General Surgeon Kelowna General Hospital Interior Health Consultant, Surgical Oncology BC Cancer Agency Centre
More informationPositron Emission Tomography in Lung Cancer
May 19, 2003 Positron Emission Tomography in Lung Cancer Andrew Wang, HMS III Patient DD 53 y/o gentleman presented with worsening dyspnea on exertion for the past two months 30 pack-year smoking Hx and
More informationPediatric Retroperitoneal Masses Radiologic-Pathologic Correlation
Acta Radiológica Portuguesa, Vol.XVIII, nº 70, pág. 61-70, Abr.-Jun., 2006 Pediatric Retroperitoneal Masses Radiologic-Pathologic Correlation Marilyn J. Siegel Mallinckrodt Institute of Radiology, Washington
More informationLiver Transplantation Evaluation: Objectives
Liver Transplantation Evaluation: Essential Work-Up Curtis K. Argo, MD, MS VGS/ACG Regional Postgraduate Course Williamsburg, VA September 13, 2015 Objectives Discuss determining readiness for transplantation
More informationLiver nodules mimicking metastatic disease
Liver nodules mimicking metastatic disease Poster No.: C-1703 Congress: ECR 2011 Type: Educational Exhibit Authors: F. Vandenbroucke, B. Ilsen, B. Op de Beeck, J. de Mey ; 1 1 2 2 3 2 3 Brussels/BE, Brussel/BE,
More informationGASTROINTESTINAL IMAGING STUDY GUIDE
GASTROINTESTINAL IMAGING STUDY GUIDE Pharynx Diverticula Foreign bodies Trauma o Motility Disorders Esophagus Diverticula Trauma Esophagitis Barrett esophagus Rings, webs, and strictures Varices Benign
More informationHepatocellular carcinoma in Sri Lanka - where do we stand?
SCIENTIFIC ARTICLE Hepatocellular carcinoma in Sri Lanka - where do we stand? R.C. Siriwardana 1, C.A.H. Liyanage 1, M.B. Gunethileke 2 1. Specialist Gastrointestinal and Hepatobilliary Surgeon, Senior
More informationLUS: Laparoscopic Ultrasound
LUS: Laparoscopic Ultrasound Dr. Bjørn Skjoldbye Herlev Hospital Copenhagen University Training Course for Advanced Oncologic Laparoscopy St. Petersburg - February 14, 2006 Equipment Laparoscopy LUS (B&K
More informationHepatocellular Carcinoma. Markus Heim Basel
Hepatocellular Carcinoma Markus Heim Basel Outline 1. Epidemiology 2. Surveillance 3. (Diagnosis) 4. Staging 5. Treatment Epidemiology of HCC Worldwide, liver cancer is the sixth most common cancer (749
More informationSteps in Assessing Fibrosis 4/30/2015. Overview of Liver Disease Associated With HCV
Overview of Liver Disease Associated With HCV Marion G. Peters, MD John V. Carbone, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco San Francisco,
More informationMRI OF FOCAL LESIONS IN
Introduction MRI OF FOCAL LESIONS IN THE NON-CIRRHOTIC LIVER Ivan Pedrosa M.D. Ph.D. Associate Professor of Radiology and Advanced Imaging Research Center University of Texas Southwestern. Dallas, TX Incidental
More informationEASL-EORTC Guidelines
Pamplona, junio de 2008 CLINICAL PRACTICE GUIDELINES: PARADIGMS IN MANAGEMENT OF HCC EASL-EORTC Guidelines Bruno Sangro Clínica Universidad de Navarra. CIBERehd. Pamplona, Spain Levels of Evidence according
More informationHepato-Pancreatico-Biliary Surgery. Dr. Ankur J. Shah. MS, DNB, MNAMS, MRCSEd (UK), FRCS (UK)
Hepato-Pancreatico-Biliary Surgery Dr. Ankur J. Shah MS, DNB, MNAMS, MRCSEd (UK), FRCS (UK) Consultant Hepato-Pancreatico-Biliary and Liver Transplant Surgeon Ansh Liver Clinic Prevention to Cure Address
More informationSimplifying liver assessment in internal medicine
Ultrasound Customer story Simplifying liver assessment in internal medicine Philips Affiniti ultrasound for elastography and contrast-enhanced ultrasound (CEUS) Where Sonography Institute, Uster, Switzerland
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,350 108,000 1.7 M Open access books available International authors and editors Downloads Our
More informationUpdate on RECIST and Staging of Common Pediatric Tumors Ethan A. Smith, MD
Update on RECIST and Staging of Common Pediatric Tumors Ethan A. Smith, MD Section of Pediatric Radiology C.S. Mott Children s Hospital University of Michigan ethans@med.umich.edu Disclosures No relevant
More informationEvangelos Chartampilas Bioclinic Hospital Thessaloniki, Greece
Evangelos Chartampilas Bioclinic Hospital Thessaloniki, Greece Hepatospecificcontrast agents Gadobenate dimeglumine (Multihance) Gadoxeticacid (Primovist) 3-5% liver uptake 50% liver uptake Hepatobiliary
More informationLiver Perfusion Analysis New Frontiers in Dynamic Volume Imaging. Case Study Brochure Chang Gung Memorial Hospital.
New Frontiers in Dynamic Volume Imaging dynamic volume CT Case Study Brochure Chang Gung Memorial Hospital http://www.toshibamedicalsystems.com Toshiba Medical Systems Corporation 2010-2011. All rights
More informationLI-RADS Reporting. Chapter 14. Primary Authors. Contributing Authors. Memorial Sloan Kettering Cancer Center
Chapter 14 LI-RADS Primary Authors Victoria Chernyak Mustafa R. Bashir Montefiore Medical Center Duke University Medical Center Contributing Authors Richard K. Do Aya Kamaya Ania Z. Kielar Donald G. Mitchell
More information